Intact fish skin graft to treat deep diabetic foot ulcers: The Odinn Trial

Join us for a groundbreaking webinar as we delve into the results of the Odinn randomized controlled trial (RCT) investigating the efficacy of intact fish skin grafts for the management of severe diabetic foot ulcers (DFUs).

Unlike previous studies, the Odinn RTC focused on complex DFUs that have penetrated tendon, capsule, bone or joint a population often challenging to treat. This large-scale trial compared the outcomes of patients receiving fish skin grafts in conjunction with standard of care versus standard care alone.

Listen to Dr. John Lantis and colleagues discuss how this innovative approach has demonstrated significantly higher wound closure rates and accelerated healing times compared to traditional methods. Learn about the potential to revolutionize the care of deep, treatment-resistant DFUs, leading to reduced amputations, improved patient quality of life, and substantial healthcare cost savings.

This webinar will provide a comprehensive overview of the study design, methodology, and key findings. Don’t miss this opportunity to gain valuable insights into the future of diabetic foot ulcer management.